The government has also initiated a study on whether Ashwagandha can be an alternative to anti-malarial drug Hydroxychloroquine (HCQ) as a potential COVID-19 preventive. Ayurvedic herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a
New Delhi. Natural compounds from Ashwagandha (Withania somnifera) and Propolis could be potential drug candidates against Covid-19. It is revealed in a collaborative study of DAILAB ( DBT-AIST International Laboratory for Advanced Biomedicine) at Indian Institute of Technology (IIT) Delhi
The Indian Institute of Technology-Delhi is collaborating with Open Health Systems Laboratory (OHSL), USA to set up an international Centre of Excellence (CoE) on computational and biomedical sciences with an initial funding of Rs 10 Crore from OHSL. “The objective
New Delhi: An agreement was signed between IIT Delhi and the All India Institute of Ayurveda (AIIA) under which projects would be launched that would aim to give “scientific validation” to the ancient medical science and integrate it with technology.
